Aster DM Healthcare Publishes Postal Ballot Notice for Executive Director Appointment
Aster DM Healthcare has published its postal ballot notice in newspapers as required under Regulation 30, seeking shareholder approval for founder Dr. Azad Moopen's appointment as Executive Director and authorization for financial assistance up to ₹1,500 crores. The e-voting process runs from March 14 to April 12, 2026, with results expected by April 14, 2026.

*this image is generated using AI for illustrative purposes only.
Aster DM Healthcare Limited has issued a postal ballot notice dated March 13, 2026, seeking shareholder approval for critical corporate matters following the board's earlier decision to appoint founder Dr. Azad Moopen as Executive Director. The company has now published this notice in newspapers as required under regulatory compliance.
Newspaper Publication and Regulatory Compliance
On March 14, 2026, the company published its postal ballot notice in Financial Express (English Language) and Andhra Jyothi (Telugu Language) newspapers, fulfilling the regulatory requirements under Regulation 30. This publication ensures wider dissemination of information to shareholders and the general public regarding the upcoming postal ballot.
| Publication Details: | Information |
|---|---|
| Publication Date: | March 14, 2026 |
| English Newspaper: | Financial Express |
| Regional Newspaper: | Andhra Jyothi (Telugu) |
| Regulatory Compliance: | Regulation 30 |
| Company Website: | www.asterdmhealthcare.in |
Postal Ballot Process and Timeline
The company has initiated the postal ballot process in compliance with SEBI regulations, with voting restricted to electronic mode only. The postal ballot notice has been sent electronically to all eligible shareholders whose email addresses are registered with the company or depositories.
| Parameter: | Details |
|---|---|
| Cut-off Date: | Friday, March 6, 2026 |
| E-voting Start: | Saturday, March 14, 2026 at 9:00 AM (IST) |
| E-voting End: | Sunday, April 12, 2026 at 5:00 PM (IST) |
| Results Declaration: | On or before Tuesday, April 14, 2026 |
| Scrutinizer: | Mr. Rajiv Balakrishnan, Beyond Compliance Corporate Services |
Special Business Items for Approval
The postal ballot seeks shareholder approval for two critical special resolutions that will shape the company's future operations and governance structure.
Executive Director Appointment
The primary resolution concerns the appointment of Dr. Mandayapurath Azad Moopen (DIN: 00159403) as Executive Director, transitioning from his current role as Managing Director. This strategic redesignation aligns with the proposed amalgamation of Quality Care India Limited with the company.
| Appointment Details: | Specifications |
|---|---|
| Term Period: | April 15, 2026 to May 28, 2028 |
| Remuneration: | Up to ₹10.00 crores per annum |
| Current Age: | 72 years |
| Board Tenure: | Since January 18, 2008 |
| Shareholding: | 1,470,676 equity shares directly |
| Beneficial Ownership: | 18,68,53,810 shares (36.06% through Union Investment) |
Financial Assistance Authorization
The second resolution seeks approval for granting loans, guarantees, or securities under Section 185 of the Companies Act, 2013, to group entities where directors may have interests.
| Financial Parameters: | Details |
|---|---|
| Maximum Limit: | ₹1,500 crores |
| Validity Period: | Three years from approval date |
| Permitted Usage: | Principal business activities only |
| Interest Terms: | Commercial rates at market conditions |
Leadership Profile and Market Performance
Dr. Azad Moopen, a Gold Medallist in MBBS from Calicut Government Medical College, has transformed the organization from a single-doctor clinic in Dubai (1987) into a leading global healthcare network spanning seven countries with over 500 healthcare facilities.
Under his leadership, the company has demonstrated consistent financial growth:
| Financial Year: | Operating Revenue (₹ crores) | Operating EBITDA (₹ crores) | PAT (₹ crores) | Market Cap (₹ crores) |
|---|---|---|---|---|
| FY25: | 4,138.00 | 806.00 | 307.00 | 24,067.00 |
| FY24: | 3,699.00 | 620.00 | 188.00 | 20,357.00 |
| FY23: | 2,983.00 | 477.00 | 147.00 | 11,970.00 |
Regulatory Compliance and Governance
The appointments have been structured in full compliance with applicable regulations, including SEBI Listing Obligations and Disclosure Requirements. The Nomination and Remuneration Committee and Audit Committee have provided their recommendations and approvals respectively.
The company has confirmed that Dr. Azad Moopen is not debarred from holding directorial positions and satisfies all conditions prescribed under Schedule V of the Companies Act. His appointment remains subject to Central Government approval as required for persons above 70 years of age.
Shareholders can access the complete postal ballot notice on the company's website and cast their votes through the NSDL e-voting platform during the specified voting period.
Historical Stock Returns for Aster DM Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.30% | +6.87% | +2.35% | +7.18% | +47.79% | +389.77% |

































